DVA
DaVita HealthCare Partners Inc
NYSE: DVA · HEALTHCARE · MEDICAL CARE FACILITIES
$155.14
+2.07% today
Updated 2026-04-30
Market cap
$9.90B
P/E ratio
15.78
P/S ratio
0.73x
EPS (TTM)
$9.51
Dividend yield
—
52W range
$101 – $159
Volume
0.8M
WallStSmart proprietary scores
64
out of 100
Grade: C+
Hold
Investment rating
6.0
Growth
B4.3
Quality
C7.0
Profitability
B+8.7
Valuation
A3/9
Piotroski F-Score
Weak
1.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$151.71
-2.21%
12-Month target
$153.33
-1.17%
Intrinsic (DCF)
$250.75
Margin of safety
+42.46%
0 Strong Buy1 Buy6 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 64.80% — strong efficiency
+ Free cash flow $395.30M — positive
+ 42.46% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 1.22 — distress zone
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $11.61B | $12.14B | $12.82B | $13.64B | $13.64B |
| Net income | $560.40M | $691.53M | $936.34M | $746.80M | $234.22M |
| EPS | — | — | — | — | $9.51 |
| Free cash flow | $961.14M | $1.49B | $1.47B | $1.31B | $395.30M |
| Profit margin | 4.83% | 5.70% | 7.31% | 5.47% | 5.47% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-15 | YALE, PHYLLIS R | Buy | 332 | — |
| 2026-03-15 | WATERS, KATHLEEN ALYCE | Buy | 8,610 | — |
| 2026-03-15 | WATERS, KATHLEEN ALYCE | Sale | 26,118 | $150.72 |
Peer comparison
Smart narrative
DaVita HealthCare Partners Inc trades at $155.14. representing a P/E of 15.78x trailing earnings. Our Smart Value Score of 64/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 1.22, it sits in the distress. TTM revenue stands at $13.64B. with profit margins at 5.47%. Our DCF model estimates intrinsic value at $250.75.
Frequently asked questions
What is DaVita HealthCare Partners Inc's stock price?
DaVita HealthCare Partners Inc (DVA) trades at $155.14.
Is DaVita HealthCare Partners Inc overvalued?
Smart Value Score 64/100 (Grade C+, Hold). DCF value $250.75.
What is the price target of DaVita HealthCare Partners Inc (DVA)?
The analyst target price is $151.71, representing -2.2% downside from the current price of $155.14.
What is the intrinsic value of DaVita HealthCare Partners Inc (DVA)?
Based on our DCF model, intrinsic value is $250.75, a +42.5% margin of safety versus $155.14.
What is DaVita HealthCare Partners Inc's revenue?
TTM revenue is $13.64B.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
1.22 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.73x
ROE64.80%
Beta0.92
50D MA$151.01
200D MA$132.71
Shares out0.07B
Float0.03B
Short ratio—
Avg volume0.8M
Performance
1 week+1.46%
1 month-1.20%
3 months+36.06%
YTD+35.93%
1 year—
3 years—
5 years—